Homepage

NIBR researcher Jennifer Allport-Anderson looks into a microscope
Stories / Discovery

A cellular drama at the heart of a researcher’s family

Jennifer Allport-Anderson hunts for cardiac cures.

Read More
Blood smear from patient with African Sleeping sickness (Centers for Disease Control and Prevention)
Stories / Discovery

Killing three diseases with one stone in the lab

Novartis researchers have discovered a compound that is showing promise against three parasites that...

Read More
Boats in Thailand
Stories / Global Impact

Experimental treatment clears malaria infections in small clinical study

Compound offers a potential tool for fighting drug-resistant malaria parasites.

Read More

Explore Novartis

News
Annual Report 2016
Careers
Job Search
News
Media Releases
Research & Development
Clinical Pipeline

Recent Updates

Featured / Jan 25

Novartis 2016 Financial Results

This morning, Novartis CEO Joe Jimenez announced fourth quarter and full year 2016 results.

Read More
Media Release / Jan 26

Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report

Read More
Media Release / Jan 25

Novartis delivered solid 2016 performance, with Growth Products[1] absorbing Gleevec US LOE; innovation momentum continued; announces share buyback

Read More
Media Release / Dec 20

Novartis bolsters ophthalmology pipeline through acquisition of Encore Vision, Inc.

Read More
View All
Facts, figures & results – it’s all here in our 2016 Annual Report: https://t.co/qsfwrnTIuB 📖📊🔬 https://t.co/c4pDiOPdM3 15 hours 26 min ago

Our Business

Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics.

Learn More